Cargando…

Developing a Canadian Real-World Evidence Action Plan across the Drug Life Cycle

Policy makers face challenges with the number of drugs for rare indications and rapidly rising costs. In facing these challenges, decision-makers see real-world evidence (RWE) as an opportunity. Health Canada and the Canadian Agency for Drugs and Technologies in Health (CADTH) recently announced the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tadrous, Mina, Ahuja, Tarry, Ghosh, Basanti, Kropp, Rhonda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Longwoods Publishing 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7294449/ https://www.ncbi.nlm.nih.gov/pubmed/32538348 http://dx.doi.org/10.12927/hcpol.2020.26225

Ejemplares similares

Development of a Multi-Criteria Decision Analysis Rating Tool to Prioritize Real-World Evidence Questions for the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration
por: Parmar, Ambica, et al.
Publicado: (2023)

Developing a framework to incorporate real-world evidence in cancer drug funding decisions: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration
por: Chan, Kelvin, et al.
Publicado: (2020)

Engaging Patients in the Canadian Real-World Evidence for Value in Cancer Drugs (CanREValue) Initiative: Processes and Lessons Learned
por: Evans, William K., et al.
Publicado: (2022)

Mapping Canadian Data Assets to Generate Real-World Evidence: Lessons Learned from Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s RWE Data Working Group
por: Dai, Wei Fang, et al.
Publicado: (2022)

Integration of real-world evidence from different data sources in health technology assessment
por: Graili, Pooyeh, et al.
Publicado: (2023)

Greater than the Sum: Applying Daily-Dose Equivalents to Antipsychotic Prescription Claims to Study Real-World Effects
por: Hayes, Kaleen N., et al.
Publicado: (2021)

The inclusion of real world evidence in clinical development planning
por: Martina, Reynaldo, et al.
Publicado: (2018)

Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration’s Reassessment and Uptake Working Group
por: Dai, Wei Fang, et al.
Publicado: (2021)

Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective
por: Azoulay, Laurent
Publicado: (2022)

Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise
por: Dai, Wei Fang, et al.
Publicado: (2021)

Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
por: Rapin, Lucile, et al.
Publicado: (2021)

Interprovincial Variation of Psychotropic Prescriptions Dispensed to Older Canadian Adults
por: Black, Cody D., et al.
Publicado: (2018)

TURNING REAL-WORLD DATA INTO ACTIONABLE EVIDENCE FOR HEALTHCARE INTERVENTIONS IN NEURODEGENERATION
por: Poulsen, Rachel, et al.
Publicado: (2022)

Best practices in the real-world data life cycle
por: Zhang, Joe, et al.
Publicado: (2022)

The Missing Reality of Real Life in Real‐World Evidence
por: Okun, Sally
Publicado: (2019)

How can real‐world evidence aid decision making during the life cycle of nonprescription medicines?
por: Csoke, Emese, et al.
Publicado: (2021)

A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022)

Prior Authorization and Canadian Public Utilization of Direct-Acting Oral Anticoagulants
por: Gao, Lulu, et al.
Publicado: (2017)

Trends in Canadian prescription drug purchasing: 2001–2020
por: Hofmeister, Mark, et al.
Publicado: (2022)

Extent of a valsartan drug shortage and its effect on antihypertensive drug use in the Canadian population: a national cross-sectional study
por: Fenna, Jennifer, et al.
Publicado: (2021)

REAL-WORLD REPRESENTATIVENESS OF CANADIAN RESEARCH SUBJECTS WITH MILD COGNITIVE IMPAIRMENT
por: Huang, Vivian, et al.
Publicado: (2019)

The Nascent Pan-Canadian Real-world Health Data Network (PRHDN)
por: Schull, Michael J., et al.
Publicado: (2017)

Action Planning and the Timescale of Evidence Accumulation
por: Tsetsos, Konstantinos, et al.
Publicado: (2015)

Building the Foundation for International Conservation Planning for Breeding Ducks across the U.S. and Canadian Border
por: Doherty, Kevin E., et al.
Publicado: (2015)

Sustainable Nephrology Action Planning (“SNAP”)—A New Committee of the Canadian Society of Nephrology
por: Stigant, Caroline
Publicado: (2022)

STaRT-RWE: structured template for planning and reporting on the implementation of real world evidence studies
por: Wang, Shirley V, et al.
Publicado: (2021)

A real‐world, observational study of erenumab for migraine prevention in Canadian patients
por: Becker, Werner J., et al.
Publicado: (2022)

Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021)

Similar Cerebral Motor Plans for Real and Virtual Actions
por: Bozzacchi, Chiara, et al.
Publicado: (2012)

Editorial: Real-world data and real-world evidence in hematologic malignancies
por: Malagola, Michele, et al.
Publicado: (2023)

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action
por: Farghaly, Mohamed Nasr Mahmoud Hassan, et al.
Publicado: (2022)

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan
por: Sagan, Selena M., et al.
Publicado: (2016)

Correction: Action Planning and the Timescale of Evidence Accumulation
por: Tsetsos, Konstantinos, et al.
Publicado: (2015)

Software life cycle management standards: real-world solutions and scenarios for savings
por: Wright, David
Publicado: (2011)

Informing real-world practice with real-world evidence: the value of PRECIS-2
por: Neta, Gila, et al.
Publicado: (2018)

Proceed with Caution When Using Real World Data and Real World Evidence
por: Kim, Hun-Sung, et al.
Publicado: (2019)

4505 Implementation of Real-World Data and Real-World Evidence in Clinical Studies
por: Pham, Jessica, et al.
Publicado: (2020)

Canadian Real‐World Outcomes of Omnipod Initiation in People with Type 1 Diabetes (COPPER study): Evidence from the LMC Diabetes Registry
por: Brown, R. E., et al.
Publicado: (2020)

Enablers and determinants of the provision of written action plans to patients with asthma: a stratified survey of Canadian physicians
por: Djandji, Fabienne, et al.
Publicado: (2017)

Real world evidence: An Indian perspective
por: Dang, Amit, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_bpidooggefbptetbv4pc26nq45